Research details developments in the Healthcare Fraud Detection Market worth USD 2,242.7 Million by 2022
The global Healthcare Fraud Detection Market is expected to reach USD 2,242.7 Million by 2022 from USD 631.0 Million in 2017, at a CAGR of 28.9%.
The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Healthcare Fraud Detection Market, along with revenue estimates & forecasts and market share analysis.
The growth of the market is attributed to a large number of fraudulent activities in healthcare; increasing number of patients seeking health insurance; the prepayment review model; growing pressure of fraud, waste, and abuse on healthcare spending; and high returns on investment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221837663
Healthcare Fraud Detection Market segmentation:
- Based on Type
- Based on Component
- Based on Delivery Model
- Based on Application
- Based on End Users
- Based on Regions
The Major Players Opearting in the Healthcare Fraud Detection Market:
Key players in the Healthcare Fraud Detection Market include IBM (US), Optum (US), SAS (US), McKesson (US), SCIO (US), Verscend (US), Wipro (India), Conduent (US), HCL (India), CGI (Canada), DXC (US), Northrop Grumman (US), LexisNexis (US), and Pondera (US).
IBM was the leading player in the global Healthcare Fraud Detection Market. The company has a strong presence in North America, Europe, Asia, and Latin America.
The company has a strong presence in the commercial and government healthcare payer markets. Moreover, it has a strong sales and distribution network in more than 175 countries. IBM invests heavily in research activities to continuously improve its product portfolio.The company focuses on inorganic strategies like acquisitions and partnerships. For instance, in April 2016, IBM acquired Truven (US), a provider of cloud-based healthcare data, analytics, and insights. This acquisition strengthened IBM’s product portfolio for fraud, waste, and abuse detection and customer base.
Geographical Detailed Analysis for Healthcare Fraud Detection Market:
North America is expected to dominate the market followed by Europe.
The large share of the North American segment is attributed to factors such as increase in the number of people seeking health insurance, increasing cases of healthcare fraud, favorable government initiatives to combat healthcare fraud, rising pressure to reduce healthcare costs, technological advancements, and greater product and service availability in this region.
Read More in Detailed (Healthcare Fraud Detection):
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062